Michael King
Stock Analyst at EF Hutton
(1.00)
# 3,607
Out of 4,735 analysts
126
Total ratings
34.15%
Success rate
-16.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $9.52 | +6,727.73% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.54 | +76,471.43% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $4.07 | +170.27% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $4.25 | +652.94% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $5.70 | +1,101.75% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $9.51 | +2,003.05% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.36 | +510.29% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $687.80 | +25.33% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $36.43 | -34.12% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.48 | +3,441.67% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $3.83 | +4,234.20% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $20.45 | +105.38% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $264.99 | +14.72% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $9.94 | +1,067.00% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.61 | +294.64% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $28 | $0.15 | +18,883.05% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $44.88 | -46.52% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $2.48 | +32,158.06% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $16.88 | +172.51% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $33.23 | +188.90% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.27 | +2,734.65% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.71 | +1,586.34% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $8.20 | +278.05% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $180 → $160 | $0.21 | +76,455.02% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $647.39 | -94.44% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $9.52
Upside: +6,727.73%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.54
Upside: +76,471.43%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $4.07
Upside: +170.27%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $4.25
Upside: +652.94%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $5.70
Upside: +1,101.75%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $9.51
Upside: +2,003.05%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.36
Upside: +510.29%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $687.80
Upside: +25.33%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $36.43
Upside: -34.12%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.48
Upside: +3,441.67%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $3.83
Upside: +4,234.20%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $20.45
Upside: +105.38%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $264.99
Upside: +14.72%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $9.94
Upside: +1,067.00%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $2.61
Upside: +294.64%
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.15
Upside: +18,883.05%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $44.88
Upside: -46.52%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $2.48
Upside: +32,158.06%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $16.88
Upside: +172.51%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $33.23
Upside: +188.90%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $1.27
Upside: +2,734.65%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.71
Upside: +1,586.34%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $8.20
Upside: +278.05%
Oct 18, 2019
Maintains: Market Outperform
Price Target: $180 → $160
Current: $0.21
Upside: +76,455.02%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $647.39
Upside: -94.44%